These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29316049)

  • 1. Evaluation of cosmetic outcome following breast-conserving therapy in trials: panel versus digitalized analysis and the role of PROMs.
    Lagendijk M; Vos EL; Nieboer D; Verhoef C; Corten EML; Koppert LB
    Breast J; 2018 Jul; 24(4):519-525. PubMed ID: 29316049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposal for a gold standard for cosmetic evaluation after breast conserving therapy: Results from the St George and Wollongong Breast Boost trial.
    Merie R; Browne L; Cardoso JS; Cardoso MJ; Chin Y; Clark C; Graham P; Szwajcer A; Hau E
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):819-825. PubMed ID: 28834326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aesthetic result after breast-conserving therapy is associated with quality of life several years after treatment. Swedish women evaluated with BCCT.core and BREAST-Q™.
    Dahlbäck C; Ullmark JH; Rehn M; Ringberg A; Manjer J
    Breast Cancer Res Treat; 2017 Aug; 164(3):679-687. PubMed ID: 28536951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aesthetic outcome following breast-conserving surgery assessed by three evaluation modalities in relation to health-related quality of life.
    Dahlbäck C; Ringberg A; Manjer J
    Br J Surg; 2019 Jan; 106(1):90-99. PubMed ID: 30160774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cosmetic outcome and quality of life are inextricably linked in breast-conserving therapy.
    Volders JH; Negenborn VL; Haloua MH; Krekel NMA; Jóźwiak K; Meijer S; M van den Tol P
    J Surg Oncol; 2017 Jun; 115(8):941-948. PubMed ID: 28334419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The COSMAM TRIAL a prospective cohort study of quality of life and cosmetic outcome in patients undergoing breast conserving surgery.
    Catsman CJLM; Beek MA; Voogd AC; Mulder PGH; Luiten EJT
    BMC Cancer; 2018 Apr; 18(1):456. PubMed ID: 29688847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative ultrasound guidance in breast-conserving surgery shows superiority in oncological outcome, long-term cosmetic and patient-reported outcomes: Final outcomes of a randomized controlled trial (COBALT).
    Volders JH; Haloua MH; Krekel NM; Negenborn VL; Kolk RH; Lopes Cardozo AM; Bosch AM; de Widt-Levert LM; van der Veen H; Rijna H; Taets van Amerongen AH; Jóźwiak K; Meijer S; van den Tol MP
    Eur J Surg Oncol; 2017 Apr; 43(4):649-657. PubMed ID: 27916314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cosmetic outcome on quality of life after breast cancer surgery.
    Kim MK; Kim T; Moon HG; Jin US; Kim K; Kim J; Lee JW; Kim J; Lee E; Yoo TK; Noh DY; Minn KW; Han W
    Eur J Surg Oncol; 2015 Mar; 41(3):426-32. PubMed ID: 25578249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Turning subjective into objective: the BCCT.core software for evaluation of cosmetic results in breast cancer conservative treatment.
    Cardoso MJ; Cardoso J; Amaral N; Azevedo I; Barreau L; Bernardo M; Christie D; Costa S; Fitzal F; Fougo JL; Johansen J; Macmillan D; Mano MP; Regolo L; Rosa J; Teixeira L; Vrieling C
    Breast; 2007 Oct; 16(5):456-61. PubMed ID: 17606373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of breast cosmetic changes with a computer-software; the breast cancer conservative treatment cosmetic results (BCCT. core) in hypofractionated whole breast irradiation after breast-conserving surgery-supplementary analysis of multicenter single-arm confirmatory trial: JCOG0906.
    Nozaki M; Kagami Y; Takahashi M; Machida R; Sekino Y; Shibata T; Ito Y; Nishimura Y; Teshima T; Ushijima H; Nagata Y; Matsumoto Y; Akimoto T; Takahashi K; Murayama S; Uno T; Tsujino K; Hamamoto Y; Nakagawa K; Kodaira T; Hiraoka M;
    Breast Cancer; 2022 Nov; 29(6):1042-1049. PubMed ID: 35861936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Different Quality of Life Assessment Modalities After Breast Cancer Therapy: A Network Meta-analysis.
    Kastora SL; Holmquist A; Valachis A; Rocco N; Meattini I; Somaiah N; Peled A; Chatterjee A; Catanuto G; Tasoulis MK; Nava MB; Poortmans P; Pusic A; Masannat Y; Karakatsanis A
    JAMA Netw Open; 2023 Jun; 6(6):e2316878. PubMed ID: 37279001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of simultaneous integrated boost, hypofractionation and oncoplastic surgery on cosmetic outcome and PROMs after breast conserving therapy.
    Lansu JT; Essers M; Voogd AC; Luiten EJ; Buijs C; Groenendaal N; Poortmans PM
    Eur J Surg Oncol; 2015 Oct; 41(10):1411-6. PubMed ID: 26260375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cosmetic Outcome Assessment following Breast-Conserving Therapy: A Comparison between BCCT.core Software and Panel Evaluation.
    Haloua MH; Krekel NM; Jacobs GJ; Zonderhuis B; Bouman MB; Buncamper ME; Niessen FB; Winters HA; Terwee C; Meijer S; van den Tol MP
    Int J Breast Cancer; 2014; 2014():716860. PubMed ID: 25328712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Objective Measurement of Cosmetic Outcomes of Breast Conserving Therapy Using BCCT.core.
    Yu T; Eom KY; Jang NY; Kim KS; Koo TR; Kwon J; Kim BH; Kang E; Kim SW; Kim JS; Kim IA
    Cancer Res Treat; 2016 Apr; 48(2):491-8. PubMed ID: 26130667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient reported outcome measures in breast cancer patients.
    Lagendijk M; van Egdom LSE; Richel C; van Leeuwen N; Verhoef C; Lingsma HF; Koppert LB
    Eur J Surg Oncol; 2018 Jul; 44(7):963-968. PubMed ID: 29678302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncoplastic Surgery: Does Patient and Medical Specialty Influences the Evaluation of Cosmetic Results?
    de Oliveira-Junior I; Brandini da Silva FC; Nazima F; Ribeiro JC; Castellani L; Zucca-Matthes G; Maciel MDS; Biller G; José da Silva J; Sarri AJ; Aloísio da Costa Vieira R
    Clin Breast Cancer; 2021 Jun; 21(3):247-255.e3. PubMed ID: 33127303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Validation of the BREAST-Q Breast-Conserving Therapy Module.
    Stolpner I; Heil J; Feißt M; Karsten MM; Weber WP; Blohmer JU; Forster T; Golatta M; Schütz F; Sohn C; Hennigs A
    Ann Surg Oncol; 2019 Sep; 26(9):2759-2767. PubMed ID: 31115853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PROMs following breast-conserving therapy for breast cancer: results from a prospective longitudinal monocentric study.
    Kindts I; Laenen A; van den Akker M; Weltens C
    Support Care Cancer; 2019 Nov; 27(11):4123-4132. PubMed ID: 30790047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Search of a Gold Standard Scoring System for the Subjective Evaluation of Cosmetic Outcomes Following Breast-Conserving Therapy.
    Racz JM; Hong NL; Latosinsky S
    Breast J; 2015; 21(4):345-51. PubMed ID: 25940058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative Ultrasound Guidance in Breast-Conserving Surgery Improves Cosmetic Outcomes and Patient Satisfaction: Results of a Multicenter Randomized Controlled Trial (COBALT).
    Haloua MH; Volders JH; Krekel NM; Lopes Cardozo AM; de Roos WK; de Widt-Levert LM; van der Veen H; Rijna H; Bergers E; Jóźwiak K; Meijer S; van den Tol P
    Ann Surg Oncol; 2016 Jan; 23(1):30-7. PubMed ID: 26486999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.